highperformr logo

Ikena Oncology's Overview

Total employees23
HeadquartersBoston
Founded2016

Ikena Oncology (NASDAQ: IKNA) is a clinical-stage biopharmaceutical company dedicated to discovering and developing novel, patient-directed, targeted therapeutics for cancer. Their pipeline focuses on biomarker-driven programs aimed at addressing unmet needs in various oncology indications. Ikena leverages its deep understanding of cancer biology and translational research to advance differentiated drug candidates designed to improve patient outcomes.

Where is Ikena Oncology's Headquarters?

HQ Function

The headquarters serves as the central hub for Ikena's research and development, clinical operations, corporate strategy, and administrative functions.

Notable Features:

Located in Boston's Seaport District, the facility includes modern laboratory and office spaces designed to foster collaboration and cutting-edge scientific research.

Work Culture:

Ikena Oncology fosters a collaborative, innovative, and science-driven work environment. The culture emphasizes a strong commitment to patients, scientific rigor, and teamwork in the pursuit of breakthrough cancer therapies.

HQ Significance:

The Boston location provides Ikena with access to a rich ecosystem of leading academic institutions, research hospitals, talent, and potential collaborators in the biotechnology industry.

Values Reflected in HQ: The headquarters' design and location reflect Ikena's commitment to innovation, scientific excellence, and being at the forefront of cancer research.

Location:

As a clinical-stage company, Ikena Oncology's global presence is primarily defined by its clinical trial activities, which may involve sites and collaborations across multiple countries to evaluate their therapeutic candidates. They also engage with regulatory authorities and research partners internationally.

Street Address:

645 Summer Street, Suite 101

City:

Boston

State/Province:

MA

Country:

USA

Ikena Oncology's Global Presence

Buying Intent Signals for Ikena Oncology

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Executive Team of Ikena Oncology

As of April 2025, Ikena Oncology' leadership includes:

Mark Manfredi, Ph.D. - President and Chief Executive Officer
Omotayo (Tayo) Fadiya, CPA, M.B.A. - Chief Financial Officer
Sergio Santillana, M.D. - Chief Medical Officer
Michelle Zhang, Ph.D. - Chief Scientific Officer
Douglas Carlson, J.D. - Chief Legal Officer & Corporate Secretary
Richard Wooster, Ph.D., FRCP - Strategic Advisor

Investors of Ikena Oncology

Ikena Oncology has been backed by several prominent investors over the years, including:

OrbiMed
Atlas Venture
Fidelity Management & Research Company
GV (Google Ventures)
Omega Funds
Beigene Ltd.
Celgene (now Bristol Myers Squibb)
Surveyor Capital (a Citadel company)

Executive New Hires/Exits in the Last 12 Months

Hire1
Exits1

Ikena Oncology announced key changes in its financial leadership over the past year, including the appointment of a new CFO and the transition of the former CFO.

Departures

Jotin Marango, M.D., Ph.D., Jotin Marango, M.D., Ph.D., transitioned from Chief Financial Officer and departed the company effective December 31, 2023, after previously serving in the role.

New Appointments:

Omotayo (Tayo) Fadiya, CPA, M.B.A., Omotayo Fadiya was appointed as Chief Financial Officer, bringing extensive experience in biotech finance. Effective November 27, 2023.

Technology (Tech Stack) used by Ikena Oncology

Discover the tools Ikena Oncology uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Ikena Oncology Email Formats and Examples

Ikena Oncology primarily uses the [first_initial][last_name]@ikenaoncology.com email format. Understanding this common pattern can be useful for professional outreach.

flast@ikenaoncology.com

Format

jdoe@ikenaoncology.com

Example

85%

Success rate

News and media

GlobeNewswireMay 9, 2024

Ikena Oncology Reports First Quarter 2024 Financial Results and Provides Corporate Update

Ikena Oncology announced its financial results for Q1 2024, highlighting progress in its clinical programs, including IK-930 targeting the Hippo pathway and IK-595, a MEK-RAF molecular glue. The company reiterated its focus on advancing its pipeline and upcoming data readouts....more

GlobeNewswireApril 2, 2024

Ikena Oncology Presents Preclinical Data on IK-595 MEK-RAF Molecular Glue Program at AACR Annual Meeting 2024

Ikena presented promising preclinical data for IK-595, its novel MEK-RAF molecular glue, at the American Association for Cancer Research (AACR) Annual Meeting. The data demonstrated potent anti-tumor activity and differentiation from existing MEK inhibitors....more

GlobeNewswireFebruary 29, 2024

Ikena Oncology Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update

Ikena reported its Q4 and full-year 2023 financial results, outlining key achievements and upcoming milestones for its targeted oncology programs. The update included progress on patient enrollment for its IK-930 and IK-595 clinical trials....more

Highperformr’s free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Ikena Oncology, are just a search away.